• Markets
  • icon
  • Companies
AVE · ASX

Avecho Biotechnology Limited (ASX:AVE)

AU$0.005

 0.001 (25.0%)
ASX:Live
12/04/2024 04:10:59 PM
Near Resistance HALO Price Momentum HALO Ords GROWTH AUS Big Candle +1
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

AVE Overview

AVE Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

About AVE

Telephone

Address

Description

Avecho Biotechnology Ltd. engages in the development and commercialization of human and animal products through its proprietary drug delivery system. It operates under the Production and Human Health segments. The Production segment focuses on manufacturing and sale of TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Human Health segment consists of delivery of pharmaceutical products through gels, injectables and patches including conduct of research and development activities. The company was founded by Mark Gregory Kerr on June 19, 1992 and is headquartered in Clayton, Australia.

AVE Price Chart

Key Stats

Market Cap

AU$12.68M

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.01

Trade Value (12mth)

AU$3,522.00

1 week

0%

1 month

0%

YTD

66.67%

1 year

0%

All time high

0.424765

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

1931m

HALO Sector

Next Company Report Date

27-Feb-25

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AVE Announcements

Latest Announcements

Date Announcements

26 March 24

Avecho commences Phase III insomnia trial

×

Avecho commences Phase III insomnia trial

26 March 24

Avecho Biotechnology Limited - Avecho commences Phase III insomnia trial (AVE-AU)

×

Avecho Biotechnology Limited - Avecho commences Phase III insomnia trial (AVE-AU)

18 March 24

Avecho to present at NWR Virtual Healthcare Conference

×

Avecho to present at NWR Virtual Healthcare Conference

18 March 24

Avecho Biotechnology Limited - Avecho to present at NWR Virtual Healthcare Conference (AVE-AU)

×

Avecho Biotechnology Limited - Avecho to present at NWR Virtual Healthcare Conference (AVE-AU)

14 March 24

Avecho meets TGA ahead of Phase III Clinical Trial

×

Avecho meets TGA ahead of Phase III Clinical Trial

14 March 24

Avecho Biotechnology Limited - Avecho meets TGA ahead of Phase III Clinical Trial (AVE-AU)

×

Avecho Biotechnology Limited - Avecho meets TGA ahead of Phase III Clinical Trial (AVE-AU)

07 March 24

AVE receives final ethics approval for Phase III CBD trial

×

AVE receives final ethics approval for Phase III CBD trial

29 February 24

Appendix 4E and Annual Report 31 December 2023

×

Appendix 4E and Annual Report 31 December 2023

29 February 24

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

20 February 24

Admission and Commencement as an ASX Debt Listing (POH-AU)

×

Admission and Commencement as an ASX Debt Listing (POH-AU)

20 February 24

Appendix 1B (POH-AU)

×

Appendix 1B (POH-AU)

20 February 24

Information Form and Checklist (POH-AU)

×

Information Form and Checklist (POH-AU)

20 February 24

Information Memorandum (POH-AU)

×

Information Memorandum (POH-AU)

20 February 24

Master Trust Deed Amending Deed (POH-AU)

×

Master Trust Deed Amending Deed (POH-AU)

20 February 24

Master Security Trust Deed Amending Deed (POH-AU)

×

Master Security Trust Deed Amending Deed (POH-AU)

20 February 24

Master Definition Schedule (POH-AU)

×

Master Definition Schedule (POH-AU)

20 February 24

Deed of Amendment (POH-AU)

×

Deed of Amendment (POH-AU)

20 February 24

Notice of Creation of Trust (POH-AU)

×

Notice of Creation of Trust (POH-AU)

20 February 24

Series Notice (POH-AU)

×

Series Notice (POH-AU)

20 February 24

General Security Deed (POH-AU)

×

General Security Deed (POH-AU)

31 January 24

December 2023 Quarterly Activities Report & Appendix 4C

×

December 2023 Quarterly Activities Report & Appendix 4C

28 November 23

Expiry of Quoted Options

×

Expiry of Quoted Options

23 November 23

Change of Director's Interest Notice x2

×

Change of Director's Interest Notice x2

22 November 23

Application for quotation of securities - AVE

×

Application for quotation of securities - AVE

09 November 23

CEO Presentation

×

CEO Presentation

AVE Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock -0.00 -0.00 N/A Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock -0.00 -0.00 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -11.8 31.6 N/A Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS $ Lock Lock Lock Lock -0.00 -0.00 N/A Lock Lock Lock
FCFPS $ Lock Lock Lock Lock -0.00 N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -19.9 30.9 N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock -12.2 N/A N/A Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.00 N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 0 N/A N/A Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.00 0.00 N/A Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock 0.00 0.00 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 73.7 -46.0 N/A Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 1,802 N/A N/A Lock Lock Lock
Basic m Lock Lock Lock Lock 1,802 N/A N/A Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 1 1 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 106.3 42.3 N/A Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 4 4 N/A Lock Lock Lock
Gross Income $m Lock Lock Lock Lock -1 1 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 53.9 200.2 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -99.8 70.2 N/A Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 200 30 N/A Lock Lock Lock
EBITDA $m Lock Lock Lock Lock -4 N/A N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -44.6 N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -519.4 N/A N/A Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 0 N/A N/A Lock Lock Lock
EBIT $m Lock Lock Lock Lock -5 -3 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -34.3 32.7 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -573.4 -271.3 N/A Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock -5 -3 N/A Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock -1 -1 N/A Lock Lock Lock
Net Income $m Lock Lock Lock Lock -3 -2 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -29.7 31.4 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -430.5 -207.4 N/A Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock -3 -2 N/A Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 0 0 N/A Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock 0 0 N/A Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 5 0 N/A Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock -3 -2 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock -131.1 48.0 N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock -4.2 -1.5 N/A Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 3 1 N/A Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 5 3 N/A Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 0 0 N/A Lock Lock Lock
Net Debt $m Lock Lock Lock Lock -3 -1 N/A Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 1 1 N/A Lock Lock Lock
Equity $m Lock Lock Lock Lock 5 2 N/A Lock Lock Lock
Invested Capital Lock Lock Lock Lock 5 3 N/A Lock Lock Lock
     Growth % Lock Lock Lock Lock 65.6 -42.9 N/A Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -65.1 -70.0 N/A Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -75.3 -96.6 N/A Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -122.1 -83.9 N/A Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -93.6 -65.5 N/A Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -84.9 -46.6 N/A Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock -413.2 N/A N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.8 N/A N/A Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -69.9 -50.4 N/A Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 6.9 3.8 N/A Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 6.6 3.3 N/A Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 67.9 51.5 N/A Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -445.4 -223.4 N/A Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 1.0 1.2 N/A Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 10.7 1.1 N/A Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.2 0.5 N/A Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 9.5 16.9 N/A Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.2 0.3 N/A Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.2 0.3 N/A Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock -572.2 -262.6 N/A Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock -86.6 -88.6 N/A Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -65.1 -70.0 N/A Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.2 1.4 N/A Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -75.3 -96.6 N/A Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 100.0 N/A N/A Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock -75.3 N/A N/A Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 34.2 325.1 N/A Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 369.3 302.7 N/A Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 403.5 627.7 N/A Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 20.1 89.8 N/A Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 383.4 538.0 N/A Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AVE Shortsell

Frequently Asked Questions

The current share price of Avecho Biotechnology Limited (AVE:ASX) is AU$0.005.
The 52-week high share price for Avecho Biotechnology Limited (AVE:ASX) is AU$0.01.
The 52-week low share price for Avecho Biotechnology Limited (AVE:ASX)? is AU$0.00.
Avecho Biotechnology Limited (AVE:ASX) does not pay a dividend.
Avecho Biotechnology Limited (AVE:ASX) does not pay a dividend.
Avecho Biotechnology Limited (AVE:ASX) has a franking level of 0%.
Avecho Biotechnology Limited (AVE:ASX) is classified in the Healthcare.
The current P/E ratio for Avecho Biotechnology Limited (AVE:ASX) is .